🎯 Ph 3 readouts in Q2 2024...

$United Therapeutics (UTHR.US)$ Phase 3
$Ironwood Pharmaceuticals (IRWD.US)$ Phase 3
$Liquidia (LQDA.US)$ Phase 3
$United Therapeutics (UTHR.US)$ Phase 3
$MorphoSys (MOR.US)$ Phase 3
$Immunocore (IMCR.US)$ Phase 3
$Crinetics (CRNX.US)$ Phase 3
$UroGen Pharma Ltd (URGN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$Capricor Therapeutics (CAPR.US)$ Phase 3
$Annexon (ANNX.US)$ Phase 3
$Lipocine (LPCN.US)$ Phase 3
$Ultragenyx Pharmaceutical (RARE.US)$ Phase 3
$Citius Pharmaceuticals (CTXR.US)$ Phase 3
$BioCardia (BCDA.US)$ Phase 3
$Agios Pharmaceuticals (AGIO.US)$ Phase 3
$Insmed (INSM.US)$ Phase 3
$Jaguar Health (JAGX.US)$ Phase 3
$G1 Therapeutics (GTHX.US)$ Phase 3
$Marinus Pharmaceuticals (MRNS.US)$ Phase 3